Departments of Gastroenterology and Hepatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Eur J Cancer Prev. 2013 Jul;22(4):299-304. doi: 10.1097/CEJ.0b013e32835b3882.
Discomfort with the collection of a stool sample is a frequently cited barrier for participation in fecal test-based colorectal cancer screening. The objective was to evaluate whether a feces collection paper enhances participation in a fecal immunochemical test (FIT)-based colorectal cancer screening program. Randomized clinical trial. Second round of a biannual Dutch FIT-based colorectal cancer screening program pilot. A random sample of 10 265 individuals from the general population, men and women aged 50-75 years at an average risk for colorectal cancer, was eligible for participation. Invitees were randomized to an FIT-only group (n=5136) or an FIT in combination with a feces collection paper group (n=5129). The main outcome measure was participation in screening. Overall, 5367 tests of 10 265 were returned (52%). In the FIT-only group, 2694 tests were returned [52%; 95% confidence interval (CI): 51-54%] versus 2673 tests in the collection paper group (52%; 95% CI: 51-54%). This difference in the participation rate was not significant (relative risk: 0.99; 95% CI: 0.97-1.04). A feces collection paper does not increase participation rates in FIT-based colorectal cancer screening. Future studies should explore other ways of facilitating participation in colorectal cancer screening programs.
对粪便样本采集的不适是参与基于粪便检测的结直肠癌筛查的常见障碍。目的是评估粪便采集纸是否能提高基于粪便免疫化学检测(FIT)的结直肠癌筛查计划的参与率。随机临床试验。荷兰基于 FIT 的结直肠癌筛查计划试点的第二轮。从一般人群中随机抽取了 10265 名年龄在 50-75 岁之间、结直肠癌平均风险的男性和女性,符合参与条件。受邀者被随机分为 FIT 组(n=5136)或 FIT 联合粪便采集纸组(n=5129)。主要观察指标为筛查参与率。共有 10265 人中有 5367 人接受了测试(52%)。在仅接受 FIT 组中,有 2694 人接受了测试[52%;95%置信区间(CI):51-54%],而在采集纸组中有 2673 人接受了测试(52%;95% CI:51-54%)。两组的参与率差异无统计学意义(相对风险:0.99;95% CI:0.97-1.04)。粪便采集纸不能提高 FIT 结直肠癌筛查的参与率。未来的研究应探索促进结直肠癌筛查计划参与的其他方法。